Sirtuin‐3 (SIRT3), a novel potential therapeutic target for oral cancerTurki Y. Alhazzazi(University of Michigan), Yvonne L. Kapila(University of Michigan)CancerNovember 29, 201010.1002/cncr.25676Cited by 217SaveCiteExport RISWatch citationsRelated PapersReceptor‐interacting protein (RIP) and Sirtuin‐3 (SIRT3) are on opposite sides of anoikis and tumorigenesis|Cancer|2012|39